187 related articles for article (PubMed ID: 7649472)
1. Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A.
Fabbretti E; Edomi P; Brancolini C; Schneider C
Genes Dev; 1995 Aug; 9(15):1846-56. PubMed ID: 7649472
[TBL] [Abstract][Full Text] [Related]
2. Exposure at the cell surface is required for gas3/PMP22 To regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases.
Brancolini C; Edomi P; Marzinotto S; Schneider C
Mol Biol Cell; 2000 Sep; 11(9):2901-14. PubMed ID: 10982389
[TBL] [Abstract][Full Text] [Related]
3. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
4. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22.
Chies R; Nobbio L; Edomi P; Schenone A; Schneider C; Brancolini C
J Cell Sci; 2003 Mar; 116(Pt 6):987-99. PubMed ID: 12584243
[TBL] [Abstract][Full Text] [Related]
6. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
7. Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22.
Brancolini C; Marzinotto S; Edomi P; Agostoni E; Fiorentini C; Müller HW; Schneider C
Mol Biol Cell; 1999 Jul; 10(7):2441-59. PubMed ID: 10397775
[TBL] [Abstract][Full Text] [Related]
8. Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients.
Lee S; Bazick H; Chittoor-Vinod V; Al Salihi MO; Xia G; Notterpek L
Am J Pathol; 2018 Mar; 188(3):728-738. PubMed ID: 29246495
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
Hanemann CO; Müller HW
Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
Sancho S; Young P; Suter U
Brain; 2001 Nov; 124(Pt 11):2177-87. PubMed ID: 11673320
[TBL] [Abstract][Full Text] [Related]
11. Glycan-independent role of calnexin in the intracellular retention of Charcot-Marie-tooth 1A Gas3/PMP22 mutants.
Fontanini A; Chies R; Snapp EL; Ferrarini M; Fabrizi GM; Brancolini C
J Biol Chem; 2005 Jan; 280(3):2378-87. PubMed ID: 15537650
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a new member of the gas3/PMP22 gene family in C. elegans.
Agostoni E; Gobessi S; Brancolini C; Schneider C
Gene; 1999 Jul; 234(2):267-74. PubMed ID: 10395899
[TBL] [Abstract][Full Text] [Related]
13. PMP22 related congenital hypomyelination neuropathy.
Fabrizi GM; Simonati A; Taioli F; Cavallaro T; Ferrarini M; Rigatelli F; Pini A; Mostacciuolo ML; Rizzuto N
J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):123-6. PubMed ID: 11118262
[TBL] [Abstract][Full Text] [Related]
14. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
[TBL] [Abstract][Full Text] [Related]
15. Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology.
Vanoye CG; Sakakura M; Follis RM; Trevisan AJ; Narayan M; Li J; Sanders CR; Carter BD
J Biol Chem; 2019 Aug; 294(32):12054-12065. PubMed ID: 31213528
[TBL] [Abstract][Full Text] [Related]
16. PMP22 overexpression causes dysmyelination in mice.
Robaglia-Schlupp A; Pizant J; Norreel JC; Passage E; Sabéran-Djoneidi D; Ansaldi JL; Vinay L; Figarella-Branger D; Lévy N; Clarac F; Cau P; Pellissier JF; Fontés M
Brain; 2002 Oct; 125(Pt 10):2213-21. PubMed ID: 12244079
[TBL] [Abstract][Full Text] [Related]
17. A novel case of concurrent occurrence of demyelinating-polyneuropathy-causing PMP22 duplication and SOX10 gene mutation producing severe hypertrophic neuropathy.
Matsuda N; Ootsuki K; Kobayashi S; Nemoto A; Kubo H; Usami SI; Kanani K
BMC Neurol; 2021 Jun; 21(1):243. PubMed ID: 34171997
[TBL] [Abstract][Full Text] [Related]
18. Sequence of human GAS3/PMP22 full-length cDNA.
Edomi P; Martinotti A; Colombo MP; Schneider C
Gene; 1993 Apr; 126(2):289-90. PubMed ID: 8482547
[TBL] [Abstract][Full Text] [Related]
19. Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
Sociali G; Visigalli D; Prukop T; Cervellini I; Mannino E; Venturi C; Bruzzone S; Sereda MW; Schenone A
Neurobiol Dis; 2016 Nov; 95():145-57. PubMed ID: 27431093
[TBL] [Abstract][Full Text] [Related]
20. Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: new facts and hypotheses.
Müller HW
Glia; 2000 Jan; 29(2):182-5. PubMed ID: 10625337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]